Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | HTR2A | P28223 | 3/20 | 0.45 |
| ▸ | HRH1 | P35367 | 2/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.43 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.43 |
| ▸ | RGS12 | O14924 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.43 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8248592 | 1.00 | ALDH1A1 (0.52) | ALDH1A1LMNATSHRHSD17B10KDM4E | |
| SCHEMBL13075266 | 1.00 | ALDH1A1 (0.52) | ALDH1A1LMNATSHRHSD17B10KDM4E | |
| Ammonia Solution, Strong SCHEMBL6810735 | 0.98 | ALDH1A1 (0.50) | ALDH1A1LMNATSHRHSD17B10KDM4E | |
| SCHEMBL2847032 | 0.85 | LMNA (0.52) | ALDH1A1LMNATSHRHSD17B10KDM4E | |
| SCHEMBL172552 | 0.82 | ALDH1A1 (0.49) | ALDH1A1LMNATSHRHSD17B10HTR2A | |
| SCHEMBL172587 | 0.82 | ALDH1A1 (0.49) | ALDH1A1LMNATSHRHSD17B10HTR2A | |
| SCHEMBL13075028 | 0.82 | ALDH1A1 (0.49) | ALDH1A1LMNATSHRHSD17B10HTR2A | |
| SCHEMBL10287179 | 0.81 | LMNA (0.48) | ALDH1A1LMNATSHRHSD17B10KDM4E | |
| SCHEMBL19286308 | 0.81 | LMNA (0.48) | ALDH1A1LMNATSHRHSD17B10KDM4E | |
| SCHEMBL23609196 | 0.79 | TAAR1 (0.57) | ALDH1A1TSHRHSD17B10HTR2AHRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1928246-B1 | A SYNERGISTIC BIOCIDE AND PROCESS FOR CONTROLLING GROWTH OF MICROORGANISMS | SOLENIS TECHNOLOGIES CAYMAN LP (CH) | 2016-08-24 | — | — | EP | claimed |
| US-8613859-B2 | Synergistic biocide and process for controlling growth of microoganisms | HERCULES INCORPORATED (US) | 2013-12-24 | — | — | US | claimed |
| CN-101296621-B | Synergistic antimicrobial agent and method for controlling microbial growth | HERCULES INC | 2012-05-30 | — | — | CN | claimed |
| US-20110159117-A1 | Synergistic Biocide and Process for Controlling Growth of Microoganisms | THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT | 2011-06-30 | — | — | US | claimed |
| US-7820060-B2 | Synergistic biocide and process for controlling growth of microorganisms | HERCULES INCORPORATED (US) | 2010-10-26 | — | — | US | claimed |
| EP-1928784-B1 | METHOD AND APPARATUS FOR PRODUCING SYNERGISTIC BIOCIDE | HERCULES INC (US) | 2009-10-14 | — | — | EP | claimed |
| CN-101296621-A | Synergistic antimicrobial agent and method for controlling microbial growth | HERCULES INC (US) | 2008-10-29 | — | — | CN | claimed |
| EP-1928784-A2 | METHOD AND APPARATUS FOR PRODUCING SYNERGISTIC BIOCIDE | Hercules Incorporated (US) | 2008-06-11 | — | — | EP | claimed |
| EP-1928246-A2 | A SYNERGISTIC BIOCIDE AND PROCESS FOR CONTROLLING GROWTH OF MICROORGANISMS | Hercules Incorporated (US) | 2008-06-11 | — | — | EP | claimed |
| US-7311878-B2 | Contacting ammonium or amine compound such as ammonia or ammonium hydroxide with halogenated oxidant in water to produce monohaloamine; converting portion of monohaloamine to dihaloamine by reducing the pH; papermaking; haloamination | HERCULES INCORPORATED (US) | 2007-12-25 | — | — | US | claimed |
| US-20070049642-A1 | Method and apparatus for producing synergistic biocide | THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT | 2007-03-01 | — | — | US | claimed |
| WO-2007025184-A2 | METHOD AND APPARATUS FOR PRODUCING SYNERGISTIC BIOCIDE | HERCULES INCORPORATED (US) | 2007-03-01 | — | — | WO | claimed |
| US-20070045199-A1 | Synergistic biocide and process for controlling growth of microorganisms | BIRKO CORPORATION | 2007-03-01 | — | — | US | claimed |
| WO-2007025087-A2 | A SYNERGISTIC BIOCIDE AND PROCESS FOR CONTROLLING GROWTH OF MICROORGANISMS | HERCULES INCORPORATED (US) | 2007-03-01 | — | — | WO | claimed |
| WO-2004018368-A1 | SYNERGISTIC BIOCIDAL MIXTURES | HERCULES INCORPORATED (US) | 2004-03-04 | — | — | WO | claimed |
| US-20040035803-A1 | Synergistic biocidal mixtures | SOLENIS TECHNOLOGIES, L.P. | 2004-02-26 | — | — | US | claimed |
| US-11952334-B2 | Cocrystals of ubiquinone and compositions comprising them | CENTER FOR INTELLIGENT RESEARCH IN CRYSTAL ENGINEERING, S.L. (ES) | 2024-04-09 | — | — | US | disclosed |
| US-20240074995-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FIRST WAVE BIO, INC. | 2024-03-07 | — | — | US | disclosed |
| WO-1997035948-A2 | WASHING POWER ENHANCER FOR DETERGENTS | BASF AKTIENGESELLSCHAFT (DE) | 1997-10-02 | — | — | WO | disclosed |
| EP-0441226-A1 | (cyanomethyl)pyridines useful as PAF antagonists | J. URIACH & CIA. S.A. (ES) | 1991-08-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240074995-A1 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | FH, CS, ECHS1 | ALDH1A1 2174/4885LMNA 3221/4885TSHR 4852/4885 |
| US-11952334-B2 | Cocrystals of ubiquinone and compositions comprising them | NDUFS6, NDUFA6, NDUFV2 | ALDH1A1 1030/4885LMNA 3428/4885TSHR 4866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.